chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Asthma, Burning sensation, Ear pain, Epistaxis
Clinical narrative: fatigue; red clear liquid drainage from one nostril; sneezing; gum numbness; eye twitching; jaw pain; itchy; joint pain; sinus burning; ear ache; red ears; bloody nose; aerobic onset asthma; irregular heart beat; head ache; stuffy; swelling; Hives; This is a spontaneous report from a contactable consumer (patient). A 34-year-old female patient received bnt162b2 (BNT162B2; Batch/Lot Number: EWO150), via an unspecified route of administration, administered in left arm, on 08Apr2021 at 11:00 (at the age of 34 years old) as dose 1, single for COVID-19 immunisation. Medical history included known allergies to penicillin. The patient was not pregnant at the time of vaccination. Concomitant medication(s) included doxycycline 20 mg; and, probiotics, both were taken for an unspecified indication, start and stop date were not reported. The patient was also taking vitamins. The patient did not receive other vaccines in four weeks. On 08Apr2021 1st day, it was reported that the patient experienced hives, swelling, headache and stuffy (medically significant). On 3rd day (12Apr2021), the patient experienced aerobic onset asthma with irregular heartbeat with exercise, and stuffy (medically significant). On 5th day (14Apr2021), the patient experienced headache, earache, red ears, itchy, joint pain, jaw pain, gum numbness, bloody nose plus sinus burning and eye twitching (medically significant). On 7th day (16Apr2021), the patient experienced red clear liquid drainage from one nostril, headache, sinus burning, sneezing, joint pain and fatigue (medically significant). The patient received steroid shot, prednisone rx and loratadine rx as treatments for the events. The patient did not have COVID prior vaccination and was not tested for COVID pot-vaccination. The outcome of the events was recovering.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Fatigue, Headache, Heart rate, Heart rate irregular
Clinical narrative: fatigue; red clear liquid drainage from one nostril; sneezing; gum numbness; eye twitching; jaw pain; itchy; joint pain; sinus burning; ear ache; red ears; bloody nose; aerobic onset asthma; irregular heart beat; head ache; stuffy; swelling; Hives; This is a spontaneous report from a contactable consumer (patient). A 34-year-old female patient received bnt162b2 (BNT162B2; Batch/Lot Number: EWO150), via an unspecified route of administration, administered in left arm, on 08Apr2021 at 11:00 (at the age of 34 years old) as dose 1, single for COVID-19 immunisation. Medical history included known allergies to penicillin. The patient was not pregnant at the time of vaccination. Concomitant medication(s) included doxycycline 20 mg; and, probiotics, both were taken for an unspecified indication, start and stop date were not reported. The patient was also taking vitamins. The patient did not receive other vaccines in four weeks. On 08Apr2021 1st day, it was reported that the patient experienced hives, swelling, headache and stuffy (medically significant). On 3rd day (12Apr2021), the patient experienced aerobic onset asthma with irregular heartbeat with exercise, and stuffy (medically significant). On 5th day (14Apr2021), the patient experienced headache, earache, red ears, itchy, joint pain, jaw pain, gum numbness, bloody nose plus sinus burning and eye twitching (medically significant). On 7th day (16Apr2021), the patient experienced red clear liquid drainage from one nostril, headache, sinus burning, sneezing, joint pain and fatigue (medically significant). The patient received steroid shot, prednisone rx and loratadine rx as treatments for the events. The patient did not have COVID prior vaccination and was not tested for COVID pot-vaccination. The outcome of the events was recovering.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia oral, Muscle twitching, Nasal congestion, Pain in jaw, Pruritus
Clinical narrative: fatigue; red clear liquid drainage from one nostril; sneezing; gum numbness; eye twitching; jaw pain; itchy; joint pain; sinus burning; ear ache; red ears; bloody nose; aerobic onset asthma; irregular heart beat; head ache; stuffy; swelling; Hives; This is a spontaneous report from a contactable consumer (patient). A 34-year-old female patient received bnt162b2 (BNT162B2; Batch/Lot Number: EWO150), via an unspecified route of administration, administered in left arm, on 08Apr2021 at 11:00 (at the age of 34 years old) as dose 1, single for COVID-19 immunisation. Medical history included known allergies to penicillin. The patient was not pregnant at the time of vaccination. Concomitant medication(s) included doxycycline 20 mg; and, probiotics, both were taken for an unspecified indication, start and stop date were not reported. The patient was also taking vitamins. The patient did not receive other vaccines in four weeks. On 08Apr2021 1st day, it was reported that the patient experienced hives, swelling, headache and stuffy (medically significant). On 3rd day (12Apr2021), the patient experienced aerobic onset asthma with irregular heartbeat with exercise, and stuffy (medically significant). On 5th day (14Apr2021), the patient experienced headache, earache, red ears, itchy, joint pain, jaw pain, gum numbness, bloody nose plus sinus burning and eye twitching (medically significant). On 7th day (16Apr2021), the patient experienced red clear liquid drainage from one nostril, headache, sinus burning, sneezing, joint pain and fatigue (medically significant). The patient received steroid shot, prednisone rx and loratadine rx as treatments for the events. The patient did not have COVID prior vaccination and was not tested for COVID pot-vaccination. The outcome of the events was recovering.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Rhinorrhoea, Sneezing, Swelling, Urticaria
Clinical narrative: fatigue; red clear liquid drainage from one nostril; sneezing; gum numbness; eye twitching; jaw pain; itchy; joint pain; sinus burning; ear ache; red ears; bloody nose; aerobic onset asthma; irregular heart beat; head ache; stuffy; swelling; Hives; This is a spontaneous report from a contactable consumer (patient). A 34-year-old female patient received bnt162b2 (BNT162B2; Batch/Lot Number: EWO150), via an unspecified route of administration, administered in left arm, on 08Apr2021 at 11:00 (at the age of 34 years old) as dose 1, single for COVID-19 immunisation. Medical history included known allergies to penicillin. The patient was not pregnant at the time of vaccination. Concomitant medication(s) included doxycycline 20 mg; and, probiotics, both were taken for an unspecified indication, start and stop date were not reported. The patient was also taking vitamins. The patient did not receive other vaccines in four weeks. On 08Apr2021 1st day, it was reported that the patient experienced hives, swelling, headache and stuffy (medically significant). On 3rd day (12Apr2021), the patient experienced aerobic onset asthma with irregular heartbeat with exercise, and stuffy (medically significant). On 5th day (14Apr2021), the patient experienced headache, earache, red ears, itchy, joint pain, jaw pain, gum numbness, bloody nose plus sinus burning and eye twitching (medically significant). On 7th day (16Apr2021), the patient experienced red clear liquid drainage from one nostril, headache, sinus burning, sneezing, joint pain and fatigue (medically significant). The patient received steroid shot, prednisone rx and loratadine rx as treatments for the events. The patient did not have COVID prior vaccination and was not tested for COVID pot-vaccination. The outcome of the events was recovering.
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Insomnia, Myalgia
Clinical narrative: muscles are very sore; can not sleep; This is a spontaneous report from a contactable consumer, the patient. A 58-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: En6205) via an unspecified route of administration in the right arm on 05Mar2021 at 13:00 (at the age of 58-year-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 09Mar2021, the patient experienced muscles are very sore and cannot sleep. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of events. The clinical outcome for the events muscle soreness and insomnia were not recovered.   No follow-up attempts are needed. No further information is expected.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Urticaria
Clinical narrative: Broke out in hives all over stomach; This is a spontaneous report from a contactable consumer, the patient. A 34-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0164) via an unspecified route of administration in the right arm on 14Apr2021 at 12:00 (at the age of 34-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma. Patient had no known allergies to food, medication or other products. Concomitant medications included ibuprofen sodium (IBUPROFEN) from an unknown date for unknown indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 15Apr2021 at 09:15, the patient experienced broke out in hives all over stomach. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the event. The clinical outcome of the event broke out in hives all over stomach was not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Alopecia, SARS-CoV-2 test
Clinical narrative: Hair loss; This is a spontaneous report from a contactable consumer, the patient. A 68-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number UNKNOWN) via an unspecified route of administration on 18Mar2021 at 11:00 (at the age of 68-years-old) as a single dose for COVID-19 immunisation. Medical history included COPD (chronic obstructive pulmonary disease). The patient had no known allergies to food, medication or other products. Concomitant medications included fluticasone propionate; salmeterol xinafoate (ADVAIR) and vitamin s (MANUFACTURER UNKNOWN); for an unknown indication from an unknown date and unknown if ongoing. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Since the vaccination, the patient had been tested for COVID-19. On 15Dec2020, the patient underwent SARS-CoV-2 test as nasal swab and the result was negative. On 22Mar2021, the patient experienced hair loss. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of event hair loss and included treatment with unspecified medication from an unknown date. The clinical outcome of the event hair loss was not resolved, at the time of this report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained. No further information is expected.
Age: 37.0
Sex: M
Vaccine: COVID19
Symptoms: Parosmia, Taste disorder
Clinical narrative: Currently have a change in my taste; Change in smell-Some things smell rancidor like rubbing alcohol, any type of cleaning/soap products like Lysol cleaning agent all smell exactly the same; Cookies, soup, sun butter, pretzel and certain chips also have the same terrible taste.; This is a spontaneous report from a contactable consumer, the patient. A 37-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 31Mar2021 at 11:00 (at the age of 37-year-old) as a single dose for COVID-19 immunisation. Medical history included migraine, kidney stones and COVID-19. Prior to the vaccination, the patient was diagnosed with COVID-19.The patient did not have any known allergies to food, medications or other products. Concomitant medications included gabapentin (MANUFACTURER UNKNOWN) for unspecified indication started from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination.  On an unknown date in 2021, the patient experienced change in the taste and smell. Some things smell rancid or like rubbing alcohol and any type of cleaning/soap products like Lysol cleaning agent, all smell exactly the same. Cookies, soup, sun butter, pretzel and certain chips also had the same terrible taste. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events change in the taste and smell and cookies, soup, sun butter, pretzel and certain chips also had the same terrible taste was not recovered at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, Paraesthesia
Clinical narrative: 'My' face felt numb; Tingly from upper lip down into 'my' jaw and neck; This is a spontaneous report from a contactable consumer, the patient. A 53-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via an unspecified route of administration in the left arm on 14Apr2021 at 09:00 (at the age of 53-years-old) as a single dose for COVID-19 immunisation. The patient reported medical history which included hypothyroidism, high blood pressure (BP), anxiety, depression, allergies, and known allergy to amoxicillin. Concomitant medications included gliclazide (CLARITIN), levothyroxine sodium (SYNTHROID), buspirone (MANUFACTURER UNKNOWN), bupropion (MANUFACTURER UNKNOWN) and hydrochlorothiazide, lisinopril (LISINOPRID) for an unknown indication since an unspecified date and is unknown if ongoing. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously took first dose of BNT162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732) via an unspecified route of administration in the left arm on 24Mar2021 at 09:00 as a single dose for COVID-19 immunisation. On 14Apr2021 at 09:30 the patient's face felt numb/tingly from upper lip down into jaw and neck. This happened approximately 20 minutes after injection. The patient did not receive any treatment for the events of face felt numb/tingly from upper lip down into jaw and neck. The clinical outcome of the events 'My' face felt numb and tingly from upper lip down into 'my' jaw and neck was resolved after approximately 30 minutes from the event start.  No follow-up attempts are needed. No further information is expected.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Chills, Ear pain, Headache, Pain
Clinical narrative: fever; Chills; aches/soreness; ear pain; headache; sick stomach; This is a spontaneous report from a contactable consumer, the patient. A 39-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE;Lot Number: Ew0162) via an unspecified route of administration in the left arm on 13Apr2021 at 11:30(at the age of 39-year-old) as a single dose for COVID-19 immunisation. Medical history included none. The patient did not have any allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL), melatonin (MANUFACTURER UNKNOWN) and loratadine (CLARITIN) for an unknown indication from an unknown date. The patient previously received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE;Lot Number: En6204) via an unspecified route of administration in the left arm on 24Mar2021 at 14:00(at the age of 39-year-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 14Apr2021 at 12:00am, the patient reported that after 12 hours symptoms started. On 14Apr2021 at 12:00am, the patient experienced chills, aches, soreness, ear pain, headache and sick stomach. On 14Apr2021 at 03:00, the patient experienced fever. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcomes of the events fever, chills, aches, soreness, ear pain, headache and sick stomach was recovering at the time of this report.    No follow-up attempts are needed. No further information is expected.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: fever; Chills; aches/soreness; ear pain; headache; sick stomach; This is a spontaneous report from a contactable consumer, the patient. A 39-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE;Lot Number: Ew0162) via an unspecified route of administration in the left arm on 13Apr2021 at 11:30(at the age of 39-year-old) as a single dose for COVID-19 immunisation. Medical history included none. The patient did not have any allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL), melatonin (MANUFACTURER UNKNOWN) and loratadine (CLARITIN) for an unknown indication from an unknown date. The patient previously received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE;Lot Number: En6204) via an unspecified route of administration in the left arm on 24Mar2021 at 14:00(at the age of 39-year-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 14Apr2021 at 12:00am, the patient reported that after 12 hours symptoms started. On 14Apr2021 at 12:00am, the patient experienced chills, aches, soreness, ear pain, headache and sick stomach. On 14Apr2021 at 03:00, the patient experienced fever. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcomes of the events fever, chills, aches, soreness, ear pain, headache and sick stomach was recovering at the time of this report.    No follow-up attempts are needed. No further information is expected.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Lymph node pain, Lymphadenopathy
Clinical narrative: Very painful, very enlarged lymphnode in left armpit.; Very painful, very enlarged lymph node in left armpit.; This is a spontaneous report from a contactable consumer, the patient. A 51-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via an unspecified route of administration in the left arm on 13Apr2021 at 17:00 (at the age of 51-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient did not have allergies to medications, food, or other products. Concomitant medication included neora fit supplements from an unknown date for unknown indication. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7534) via an unspecified route of administration in the left arm on 23Mar2021 at 10:00 (at the age of 51-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 14Apr2021 at 10:00, the patient experienced very painful and very enlarged lymph node in left armpit. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive treatment for the reported events. The clinical outcome of the events very painful and very enlarged lymph node in left armpit was resolving at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Lymphadenopathy, Pain, Pyrexia
Clinical narrative: Fever; Chills; body aches; swollen lymph node under left arm; This is a spontaneous report from a contactable consumer, the patient. A 32-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EP7533) via an unspecified route of administration in the left arm on 14Apr2021 at 12:45 (at the age of 32-years-old) as a single dose for COVID-19 immunisation.The patient had no medical history. The patient did not receive any medications within two weeks of vaccination. The patient previously received DITROPAN for unknown indication and experienced drug allergy. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8727) via an unspecified route of administration in the left arm on 24Mar2021 at 12:45 (at the age of 32-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 15Apr2021 at 04:00, the patient experienced fever, chills, body aches and swollen lymph node under left arm. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcomes of the events fever, chills, body aches and swollen lymph node under left arm were resolving at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Heart rate, Heart rate increased
Clinical narrative: Heart rate of 85 bpm for seven hours; This is a spontaneous report from a contactable consumer, the patient. A 58-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 14Apr2021 at 11:45 (at the age of 58-years-old) as a single dose for COVID-19 immunisation. The patient had no other medical history. The patient did not have any allergies to food, medications and other products. Concomitant medications taken within two weeks of vaccination included atorvastatin calcium (MANUFACTURER UNKNOWN) from an unknown date for an unknown indication. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date (age at vaccination unknown) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 14Apr2021 at 22:00, the patient experienced heart rate of 85 beats per minute for seven hours. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the event. The clinical outcome of the event heart rate of 85 beats per minute for seven hours was resolved on 15Apr2021 at 05:00.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspepsia, Headache, Nausea, Pain in extremity
Clinical narrative: Heartburn; Nauseous; Headache; Painful arm that was expected; This is a spontaneous report from a contactable consumer, the patient. A 34-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0153) via an unspecified route of administration in the left arm on 14Apr2021 at 18:30 (at the age of 34-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies. Concomitant medications were not reported. Prior vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 15Apr2021 at 07:00, the patient was nauseous with heartburn, accompanied by headache and the patient expected painful arm. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of reported events. The clinical outcome of events nauseous, heartburn, headache and painful arm that was expected was recovering at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Lymph node pain, Lymphadenopathy
Clinical narrative: Pain and swelling of lymph nodeabove collarbone; swelling of lymph node above collarbone; This is a spontaneous report from a contactable consumer, the patient. A 30-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 09Apr2021 at 16:00 (at the age of 30-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had reported no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL), fexofenadine hydrochloride (ALLEGRA) bupropion hydrochloride (WELLBUTRIN) all were from unknown date and for unspecified indication, and unknown medication from unknown date for birth control. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 15Apr2021 at 17:00, noticed onset 6 days after injection, the patient experienced pain and swelling of lymph node above collarbone on the same side as the injection. The events did not result in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as the result of adverse events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events pain and swelling of lymph node above collarbone on the same side as the injection was not recovered at the time of report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Computerised tomogram, Migraine with aura
Clinical narrative: Two days after first dose of vaccine, the patient started horrific debilitating migraines with aura which was not having prior to shot.; This is a spontaneous report from a contactable consumer, the patient. A 37-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Er8730) via an unspecified route of administration in the left arm on 25Mar2021 at 10:45 (at the age of 37-year-old) as a single dose for COVID-19 immunisation. Medical history included methylenetetrahydrofolate reductase gene mutation (MTHFR), prothrombin III, factor II, hypertension, anxiety, asthma and gastroesophageal reflux disease (GERD). The patient previously took (LEVAQUIN) for unknown indication since an unknown date and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included hydrochlorothiazide (MANUFACTURER UNKNOWN) and buspirone hydrochloride (MANUFACTURER UNKNOWN); both were taken for unknown indication since unknown date within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 27Mar2021, two days after first dose of vaccine, the patient started horrific debilitating migraines with aura which was not there prior to shot. They continued daily (multiple times) for 3 weeks after. The event resulted in doctor or other healthcare professional office/clinic visit (neurologist visit). Therapeutic measures were taken as a result of the event and included treatment with unknown medication from an unknown date in 2021. On an unknown date the patient underwent computerized tomogram (CAT) scan and the result was unknown. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event two days after first dose of vaccine, the patient started horrific debilitating migraines with aura which was not having prior to shot was resolving at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Amnesia, Feeling abnormal
Clinical narrative: terrible brain fog; Loss of short term memory.; This is a spontaneous report from a contactable consumer, the patient. A 52-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on an unknown date (at the age of 52-year-old) as a single dose for COVID-19 immunisation. Medical history included protein s deficiency, factor v leiden mutation, mthfr gene mutation, migraine and deep vein thrombosis. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included apixaban (ELIQUIS) and fremanezumab vfrm (AJOVY) from an unknown date for unknown indication. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date in Apr2021, the patient experienced terrible brain fog and loss of short-term memory. No therapeutic measures were taken as a result of the events. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care.  Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome for the events confused and short-term memory loss were not recovered at the time of the report.  No follow-up attempts are needed; information about lot number cannot be obtained.
Age: 37.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Cough, Fatigue, Headache, Pain
Clinical narrative: Coughing; Body aches; Fever of 101; Headache; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 37-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EP6955) via an unspecified route of administration in the left arm on 14Apr2021 (at the age of 37-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medications included ibuprofen (MANUFACTURER UNKNOWN) received from an unknown date for unknown indication. The patient previously took the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 24Mar2021 (at the age of 37-years-old) as a single dose for COVID-19 immunisation. On 14Apr2021 at 21:00, the patient experienced body aches, fever of 101, headache, fatigue and coughing. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events body aches, fever of 101, headache, fatigue and coughing was resolving at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 37.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Coughing; Body aches; Fever of 101; Headache; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 37-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EP6955) via an unspecified route of administration in the left arm on 14Apr2021 (at the age of 37-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medications included ibuprofen (MANUFACTURER UNKNOWN) received from an unknown date for unknown indication. The patient previously took the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 24Mar2021 (at the age of 37-years-old) as a single dose for COVID-19 immunisation. On 14Apr2021 at 21:00, the patient experienced body aches, fever of 101, headache, fatigue and coughing. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events body aches, fever of 101, headache, fatigue and coughing was resolving at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Muscle spasms
Clinical narrative: Charlie horses and cramping on left side of my body especially in left thigh. Started 20 min after.; Charlie horses and cramping on left side of my body especially in left thigh. Started 20 min after.; But by 8pm I was tired.; This is a spontaneous report from a contactable consumer, the patient. A 30-year-old female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via an unspecified route of administration in the left arm on 14Apr2021 at 14:00 (at the age of 30-year-old) as a single dose for COVID-19 immunisation. Medical history included slight nerve damage and allergic to mangoes. Concomitant medications included amitriptyline (MANUFACTURER UNKNOWN) 25mg daily for an unknown indication from an unknown date. Prior to vaccination, it was unknown whether the patient was diagnosed with COVID-19.  Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 14Apr2021 at 14:30 the patient experienced Charlie horses and cramping on left side of the body especially in left thigh, which started 20 min after. It went away in the evening of the day the patient got the shot, but by 8pm was tired. The patient felt okay the morning of reporting but by evening had intense Charlie horsing on the left side again and even into the arm and back. The patient was told to go to the ER at the onsite vaccine aftercare if she still had cramping continuing later. So, the patient would probably call the doctor then go. The patient was not really sure what to do, as Charlie horses were not normal and it was making her nervous. It was unknown whether therapeutic measures were taken as a result of the events. The clinical outcome of the event Charlie horses, cramping on left side of the body especially in left thigh and tired were not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Body temperature, Chills, Fatigue, Headache
Clinical narrative: 101.7 temperature; Swelling of face; joint pain; muscle pain; headache; chills; tired; lump in injection spot; This is a spontaneous report from a contactable consumer, the patient. A 50-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EWO150) via an unspecified route of administration in the right arm on 13Apr2021 at 21:30 (at the age of 50-year-old) as a single dose for COVID-19 immunisation. Medical history included ulcerative colitis, blood pressure high and allergies. The patient received unspecified medications within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 14Apr2021 the patient experienced 101.7 temperature, swelling of face, joint pain, muscle pain, headache, chills, tired and lump in injection spot. The patient called doctor and was waiting to hear from them. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the events. On an unknown date, the patient underwent body temperature and the result was 101.7 (units unspecified). Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event 101.7 temperature. swelling of face, joint pain, muscle pain, headache, chills, tired, lump in injection spot was not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Swelling face, Vaccination site mass
Clinical narrative: 101.7 temperature; Swelling of face; joint pain; muscle pain; headache; chills; tired; lump in injection spot; This is a spontaneous report from a contactable consumer, the patient. A 50-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EWO150) via an unspecified route of administration in the right arm on 13Apr2021 at 21:30 (at the age of 50-year-old) as a single dose for COVID-19 immunisation. Medical history included ulcerative colitis, blood pressure high and allergies. The patient received unspecified medications within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 14Apr2021 the patient experienced 101.7 temperature, swelling of face, joint pain, muscle pain, headache, chills, tired and lump in injection spot. The patient called doctor and was waiting to hear from them. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the events. On an unknown date, the patient underwent body temperature and the result was 101.7 (units unspecified). Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event 101.7 temperature. swelling of face, joint pain, muscle pain, headache, chills, tired, lump in injection spot was not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Chills, Diarrhoea, Nausea, Pain
Clinical narrative: Chills; Aching; Nausea; Diarrhea; Weakness; This is a spontaneous report from a non-contactable consumer, the patient. A 71-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL8982) via an unspecified route of administration in the right arm on 02Mar2021 at 09:30 (at the age of 71-years-old) as a single dose for COVID-19 immunisation. The patients' medical history included COVID-19. The patient did not have any known allergies to medications, food or other products. Prior to the vaccination, the patient was diagnosed with COVID-19. Concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 23Mar2021, the patient experienced chills, aching, nausea, diarrhea and weakness. Since the vaccination, the patient had not been tested for COVID-19. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome for the events chills, aching, nausea, diarrhea and weakness were resolved on an unspecified date in 2021.   No follow-up attempts are possible. No further information is expected.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal, Heart rate, Heart rate increased, Sleep disorder
Clinical narrative: Resting heart rate over 90 bpm; Woke up at night; Felt like had drank several highly caffeinated beverages; This is a spontaneous report from a non-contactable consumer, the patient. A 39-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration in the left arm on 07Apr2021 at 10:00 (at the age of 39-years-old) as a single dose for COVID-19 immunisation. Medical history included hypothyroidism, postpartum depression and seasonal allergies. Concomitant medications included loratadine (CLARITIN), fluoxetine (MANUFACTURER UNKNOWN) and levothyroxine (MANUFACTURER UNKNOWN); all for an unknown indication from an unknown date and unknow if ongoing. The patient previously took sulfamethoxazole, trimethoprim, (BACTRIM) from an unknown date and experienced drug allergy. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 10Apr2021 at 01:00, the patient experienced resting heart rate over 90 bpm (beats per minute), woke her up at night and would not decrease for several hours, it felt like she had drunk several highly caffeinated beverages. RHR (rapid heart rate) varied between 80 - 90 bpm (beats per minute) for 48 hours, then returned to normal after 72 hours. The events resulted in doctor or other healthcare professional office/clinic visit. No therapeutic measures were taken as a result of the reported events. The clinical outcome of the event resting heart rate over 90 bpm was resolved on 13Apr2021 at 01:00 (after the duration of 72 hours), events woke up at night felt like had drank several highly caffeinated beverages were resolved on an unspecified date in Apr2021.   No follow-up attempts are possible. No further information is expected.
Age: 45.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Influenza like illness, Lymph node pain, Vaccination site pain, Vaccination site swelling
Clinical narrative: Lymph nodes inarmpit of arm that was injected became tender about 2 days postinjection and stayed tender for another 5 days.; Local pain, and swelling at injectionsite starting day after injection andlasting about 4 days.; Local pain, and swelling at injectionsite starting day after injection andlasting about 4 days.; Headache that lasted for about 3 days, starting about 30 min post injection.; Feeling unwell (flu-like symtpoms) for about 36 hours.; This is a spontaneous report from a non-contactable consumer, the patient. A 45-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) via an unspecified route of administration in the left arm on 04Apr2021 at 09:45 (at the age of 45-year-old) as a single dose for COVID-19 immunisation. Medical history included kidney stones. Concomitant medications included allopurinol (MANUFACTURER UNKNOWN) indicated for kidney stones from unspecified date. The patient had no known allergies. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6208) via an unspecified route of administration in the right arm on 14Mar2021 at 09:30 as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 04Apr2021 at 10:15, 30 minutes post injection, the patient experienced headache and felt unwell (flu-like symptoms). On 05Apr2021, the patient experienced local pain and swelling at injection site. On 06Apr2021, the patient felt that lymph nodes in armpit of arm that was injected became tender about 2 days post injection. No therapeutic measures were taken as a result of these events. These events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the event headache was recovered on 07Apr2021, after the duration of about 3 days. The clinical outcome of the event flu-like symptoms was recovered, after the duration of 36 hours. The clinical outcome of the events local pain and swelling at injection site was recovered on 09Apr2021, after the duration of about 4 days. The clinical outcome of the event tender lymph nodes was recovered on 11Apr2021, after the duration of 5 days.  No follow-up attempts are possible. No further information is expected
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: Shingles in the lower back.; This is a spontaneous report from a contactable consumer, the patient. A 49-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: UNKNOWN) via an unspecified route of administration in the left arm on 01Apr2021 at 14:00 (at the age of 49-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any medications within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient had no known allergies to food, medication and other products. On 08Apr2021 at 09:00, the patient experienced shingles in the lower back and the patient never experienced shingles or herpes and did not had sexual relationships. The patient was healthy and did not take any medications. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of the event which included treatment with antibiotic cream (MANUFACTURER UNKNOWN). Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event shingles in the lower back was not recovered at the time of this report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.